SHARE
COPY LINK

ASTRAZENECA

Today in Norway: A roundup of the latest news on Monday

Find out what's going on in Norway on Monday with The Local's short roundup of important news.

Today in Norway: A roundup of the latest news on Monday
Ålesund a city on Norways west coast. Photo by Torbjorn Sandbakk on Unsplash

Expert committee to deliver its verdict on the AstraZeneca and Johnson & Johnson vaccines

The committee was set up to make a comprehensive risk assessment of both vaccines and whether or not they should be used in Norway’s vaccination program.

AstraZeneca has been on pause since March 11th due to suspected serious side effects, including blood clots.

Johnson & Johnson had voluntarily delayed its European rollout over concerns due to reported blood clots.

READ MORE: Norway delays final decision on withdrawal of AstraZeneca vaccine

The two vaccines are based on the same technology.

If Norway decides against using the two vaccines in its vaccination program, then the doses could either be withdrawn entirely or only be administered to those who voluntarily opt to receive AstraZeneca and Johnson & Johnson.

The committee will deliver its verdict to government later today. The committee includes doctors, statisticians, lawyers and economists.

Minister believes immigrants in Norway should be moved forward in the vaccine queue

Culture Minister Abid Raja said that government should prioritise certain immigrant groups for vaccination.

“The health authorities should consider whether certain immigrant groups should be given priority in the vaccine queue when Pakistani immigrants, for example, have a 24 percent higher hospital admission rate,” Raja told state broadcaster NRK.

Research has shown that some immigrant groups are more likely to develop serious illness and have higher rates of mortality when they are infected with Covid-19. The research indicated that people from South Asian backgrounds are more likely to develop a more severe illness with Covid-19.

Director of Infection Control at the Norwegian Institute of Public Health, Geir Bukholm, has said the institute is constantly assessing how vaccines should be prioritised.

115 students infected with Covid-19 after party

A total of 115 Russ students have been infected following a party in Rogland, Western Norway

Russ is considered a rite of passage for final year high school students in Norway and takes place between the end of April and May 17th. Students travel around in special party busses and take part in celebrations and parties before taking their final exams.

In addition to the 115 students that have been infected, 16 close contacts have also contracted Covid-19.

Infection is believed to have spread when 1,000 Russ students travelled to a party.

309 cases of Coronavirus registered in Norway

309 new cases of Covid-19 were registered in Norway on Sunday.

This is 102 fewer cases than the 7-day average of 411.

63 new cases of coronavirus were recorded in Oslo

The R-number or reproduction rate in Norway is currently 0.7. This means that the pandemic is receding in Norway as for every ten people that are infected, they will, on average, only infect another seven people.

Total number of reported Covid-19 cases. Source: NIPH

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS